Skip to main content Skip to main navigation menu Skip to site footer

Sleeve gastrectomy and pancreas omentoplasty improved β cell insulin expression and interleukin-1β serum level in non-obese diabetes mellitus rat

  • Erlangga Dimas ,
  • Abdul Mughni ,
  • Chemy Wiryawan ,
  • Vito Mahendra ,
  • Ignatius Riwanto ,


Background: Diabetes mellitus is one of the health problems that is growing rapidly today. In Asia, majority of the population are non-obese with Type 2 Diabetes Mellitus (T2DM). Two main defects of T2DM, insulin resistance and impaired insulin secretion due to reduced pancreatic β cells. Persistent metabolic stress due to hyperglycemic conditions, causes inflammation of the islets of Langerhans. Interleukin-1β (IL-1β) signaling is the most frequent pathway inducing β cell dysfunction. The bariatric Sleeve Gastrectomy (SG) procedure increases particular hormone which stimulates β cell growth and pancreatic insulin production. Aside from the role as a blood glucose regulator, insulin also plays a role in anti-inflammatory modulation. Omentoplasty can be used to wrap organ or tissue structures. The Omentum has unique biological functions, including promote tissue regeneration and anti-inflammatory effect. The study evaluates the effect of Sleeve Gastrectomy and pancreas Omentoplasty procedures on β cell insulin expression and Interleukin-1β (IL-1β) serum levels in non-obese diabetes mellitus subjects.

Methods: Experimental study with "post-test control group design" on 27 rats with Diabetes Mellitus was divided into 3 groups: K (control), P1 (Sleeve Gastrectomy), P2 (Sleeve Gastrectomy + Omentoplasty). 10 days after procedure, we evaluated the insulin expression of β cells using monoclonal antibody anti-insulin stain and IL-1β serum levels using rat IL-1β Enzyme-Linked Immunosorbent Assay (ELISA) kit. Statistical analysis with Kruskal Wallis and Mann Whitney test. Correlation test with Spearman.

Results: β cell insulin expression increased in P2 (p=0.020), compared to control. While the IL-1β serum levels reduced significantly in all groups (p<0.001) compared to control. Moderate negative correlation (r = -0.476) between β cell insulin expression and IL-1β serum levels.

Conclusion: Sleeve gastrectomy and omentoplasty increased β cell insulin expression and decreased IL-1 β serum levels in non-obese rats with diabetes mellitus.


  1. IDF Diabetes Atlas 9th edition. Worldwide toll of diabetes. Brussels: The International Diabetes Federation (IDF); 2019 [cited 2020 June 8]. Available from:
  2. Widyaningrum, Gita L. Lack of awareness, causes of the high rate of diabetes in indonesia. National Geographic Indonesia; 2019 Nov 15 [cited 2020 June 9]. Available from: kurangnya-kesadaran-penyebab-tingginya-angka-diabetes-di-indonesia?page=all
  3. International Diabetes Federation. Type 2 diabetes. Brussels: The International Diabetes Federation (IDF); 2020 [updated 2020 jan 10; cited 2020 June 11]. Available from:
  4. Saori K, Kazuo I, Masatoshi M, Kimihiko A. Prevalence and characteristics of non-obese diabetes in japanese men and women: the yuport medical checkup center study. Journal of Diabetes. 2015;7:523-530.
  5. Zhenzhu T, Zhifeng F, Wei H, Zhanhua L, Yuzhu C, ZHongyou L, et al. Non-obese diabetes and its associated factors in an underdeveloped area of south china guangxi. Int J Environ Res Public Health. 2016;13:976.
  6. Idowu O, Mina F, Pousettef H. The pathophysiology of type 2 diabetes mellitus in non-obese individuals: an overview of the current understanding. Cureus. 2020;12(4):e7614.
  7. Shaoping D, Marko V, Xiaolun H, Nicolai D, Moh-moh L, Adam F, et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes. 2004;53:624-632.
  8. Yoo JP, Minna W. Pancreatic β cells: gatekeepers of type 2 diabetes. J Cell Biol. 2019;218(4):1094-1095.
  9. Sotirios T, Alexios SA, Evangelos O, George AP, Georgia V, Spyridon P, et al. The role of inflammation in diabetes: current concepts and future perspectives. European Cardiology Review. 2019;14(1):50-9.
  10. Qiang S, Jia L, Feng G. New insights into insulin: the anti-inflammatory effect and its clinical relevance. World J Diabetes. 2014;5(2):89-96.
  11. Attit B, Sheyu L, Niharika D, Guanjian L, Haoming T. Bariatric surgery for type 2 diabetes mellitus in patients with BMI <30 kg/m2: a systematic review and meta-analysis. PLoS ONE. 2015;10(7):e0132335.
  12. Ninh TN, Stacy AB, John MM, Jaime P, Raul JR, editor. The ASMBS textbook of bariatric surgery - second edition. Switzerland: Springer Nature Switzerland AG;2020. p. 654.
  13. Henry B, Jane NB. Metabolic (bariatric and nonbariatric) surgery for type 2 diabetes: a personal perspective review. Diabetes Care. 2019;42:331–340.
  14. Renhong H, Xusheng D, Hongbing F, Qingping C. Potential mechanisms of sleeve gastrectomy for reducing weight and improving metabolism in patients with obesity. Surgery for Obesity and Related Diseases. 2019;15:1861–72.
  15. Daniel JD. The cardiovascular biology of glucagon-like peptide-1. Cell Metabolism. 2016;24:15-30.
  16. Pai, Ashwin. Omentoplasty. New York: Medscape; 2019 March 11 [cited 2020 June 18]. Available from:
  17. Valerio DN. Omentum a powerful biological source in regenerative surgery. Regenerative Therapy. 2019; 11:182-191.
  18. Asghar G, Saeedeh K, Sajad J. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiologica Hungarica. 2014;101(4):408–20.
  19. Soebagijo AS, Hermina N, Achmad R, Pradana S, Ketut S, Asman M, et al. Consensus on the management and prevention of type 2 diabetes mellitus in indonesia. Jakarta: Pengurus Besar Perkumpulan Endokrinologi Indonesia (PB PERKENI); 2015. p. 11-14.
  20. Raquel V, Selma BS, Elena SL, Ana LM, Patricia S, Sajan J, et al. Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome strategies for in vivo administration: Part-II. J Clin Med. 2019;8:1332.
  21. IDF Diabetes Atlas 9th edition. Individual, social and economic impact - diabetes affects the health of individuals, societies and economies. Brussels: The International Diabetes Federation (IDF); 2019 [cited 2020 June 8]. Available from:
  22. Vigneshwaran B, Wahal A, Aggarwal S, Priyadarshini P, Bhattacharjee H, Khadgawat R, Yadav R. Impact of Sleeve Gastrectomy on Type 2 Diabetes Mellitus, Gastric Emptying Time, Glucagon-Like Peptide 1 (GLP-1), Ghrelin and Leptin in Non-morbidly Obese Subjects with BMI 30-35.0 kg/m2: a Prospective Study. Obes Surg. 2016;26(12):2817-2823.

How to Cite

Dimas, E., Mughni, A., Wiryawan, C., Mahendra, V., & Riwanto, I. (2021). Sleeve gastrectomy and pancreas omentoplasty improved β cell insulin expression and interleukin-1β serum level in non-obese diabetes mellitus rat. Bali Medical Journal, 10(1), 460–466.